Ask AI

Capsule Summary Slidesets

Share

Program Content

Activities

ACTG A5391 DO IT
ACTG A5391/DO-IT Trial: Switching to DOR ± TDF vs Continuing INSTI + TAF/FTC in People With Obesity and HIV Infection
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 15, 2025

Expires: January 14, 2026

Ulonivirine and Islatravir
Switch to Ulonivirine + Islatravir in Adults With Virologically Suppressed HIV-1: Phase IIb Trial
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 15, 2025

Expires: January 14, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by educational grants from Gilead Sciences, Inc., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare

Partners

IAS

ProCE Banner